Clinical Trial: Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07667673) titled 'Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH' on June 06.

Brief Summary: The MIRROR-PAH is a single-center, prospective, observational cohort study evaluating the incremental value of multimodality imaging-derived right ventricular characteristics for risk stratification in patients with Group 1 pulmonary arterial hypertension (PAH). The study aims to determine whether incorporation of echocardiographic and cardiac magnetic resonance (CMR)-derived right ventricular parameters into established non-invasive risk assessment models results in risk reclassification and improves identificatio...